|
KMID : 0381920090390020081
|
|
Korean Journal of Microscopy
2009 Volume.39 No. 2 p.81 ~ p.87
|
|
|
The Preventive Effect of Captopril on VEGF Expression in Streptozotocin-induced Diabetic Retiniopathy
|
|
|
|
|
Abstract
|
|
|
|
Diabetic retinopathy is one of major complications of diabetes mellitus, which is associated with the dysfunction of retina. It has been reported that the onset of diabetic retinopathy is related to the activation of renin-angiotensin system (RAS). Angiotensin converting enzyme (ACE), which converts angiotensin I into angiotensin II, is a key component of RAS. Among many growth factors, vascualr endothelial growth factor (VEGF) is an important cytokine in the neovasculization of retina, which is a characteristics of diabetic retinopathy. However, the relationship between ACE and VEGF was not elucidated in diabetic retinopathy. Thus, this study was conducted to examine the protective effect of captopril, an ACE inhibitor, in the retina of streptozotocin (STZ)-treated diabetic rats. In present study, STZ-treated diabetic rats exhibited the increase of VEGF levels in serum and retina. The serum levels of VEGF in STZ-treated diabetic rats was not blocked by the treatment of captopril. However, the retina levels of VEGF in STZ-treated diabetic rats was blocked by the treatment of captopril, suggesting the local action of captopril in retina. Immunohistochemical analysis also revealed that the retina of STZ-treated diabetic rats manifested the increase of ganglion cell layers, outer nuclear layers, and inner nuclear layers, which were also prevented by the treatment of captopril. In conclusion, captopril prevented the expression of VEGF in the retina of STZ-treated diabetic rats.
|
|
|
KEYWORD
|
|
|
Angiotensin converting enzyme, Retina, Vascular endothelial growth factors, Diabetic retinopathy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|